Dr. Bupathi is a board-certified medical oncologist and joined Rocky Mountain Cancer Centers in 2017. He specializes in solid tumors with an advanced subspecialty expertise in genitourinary cancers (adrenal, bladder, kidney, penile, prostate, and testicular).  He has a strong interest in the field of personalized medicine and how genomics and molecular pathways impact cancer treatment options. Dr. Bupathi is the Co-Chair for the US Oncology Genitourinary Cancer Research Program and serves as principal investigator for many Phase 1, Phase II, and Phase III studies. He emphasizes the importance of participating in clinical research trials whenever possible to ensure his patients are receiving the most up-to-date, cutting edge treatment for their disease.

In addition to Rocky Mountain Cancer Centers, Dr. Bupathi also sees patients for Phase I clinical research trials at Sarah Cannon Research Institute in Denver.